📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model. (2020)

First Author: Felce SL

Attributed to: University of Oxford Confidence in Concept Scheme – Round 5 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fonc.2020.00448

PubMed Identifier: 32309216

Publication URI: http://europepmc.org/abstract/MED/32309216

Type: Journal Article/Review

Volume: 10

Parent Publication: Frontiers in oncology

ISSN: 2234-943X